Literature DB >> 12126646

HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion.

Davide Agnello1, Haichao Wang, Huan Yang, Kevin J Tracey, Pietro Ghezzi.   

Abstract

High-mobility group protein-1 (HMG-1 also termed HMGB-1), a DNA-binding protein, regulates gene transcription and stabilizes nucleosome formation. HMG-1 was recently implicated as a cytokine, because it is a late-acting mediator of endotoxin lethality that induces the release of pro-inflammatory cytokines from monocytes. Here it is shown that administration of HMG-1 into the cerebral ventricles decreases food intake (food intake=4.6g/mouse in controls vs 1.6g/mouse after 1 microg HMG-1 i.c.v.; P <0.05). Intracerebroventricular HMG-1 induced an increased in TNF and IL-6 expression in the brain, and mediated taste aversion with potencies equivalent to LPS. In a model of endotoxemia, passive immunization with anti-HMG-1 antibodies attenuated the development of hypophagia, indicating that HMG-1 is a mediator of sickness behaviour associated with endotoxemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126646     DOI: 10.1006/cyto.2002.0890

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  41 in total

Review 1.  Anorexia in cancer: role of feeding-regulatory peptides.

Authors:  Simona Perboni; Akio Inui
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

2.  Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1.

Authors:  Shu Zhu; Wei Li; Jianhua Li; Andrew E Sama; Haichao Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-20

Review 3.  Potential role of High mobility group box 1 in hepatocellular carcinoma.

Authors:  Rong-Rong Zhou; Xu-Yuan Kuang; Yan Huang; Ning Li; Ming-Xiang Zou; Dao-Lin Tang; Xue-Gong Fan
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

4.  High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage.

Authors:  Takashi Nakahara; Ryosuke Tsuruta; Tadashi Kaneko; Susumu Yamashita; Motoki Fujita; Shunji Kasaoka; Teruto Hashiguchi; Michiyasu Suzuki; Ikuro Maruyama; Tsuyoshi Maekawa
Journal:  Neurocrit Care       Date:  2009-09-24       Impact factor: 3.210

Review 5.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

Review 6.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 7.  High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.

Authors:  Valeria Chirico; Antonio Lacquaniti; Vincenzo Salpietro; Caterina Munafò; Maria Pia Calabrò; Michele Buemi; Teresa Arrigo; Carmelo Salpietro
Journal:  Eur J Pediatr       Date:  2014-05-09       Impact factor: 3.183

8.  Scolopendra subspinipes mutilans protected the cerulein-induced acute pancreatitis by inhibiting high-mobility group box protein-1.

Authors:  Il-Joo Jo; Gi-Sang Bae; Kyoung-Chel Park; Sun Bok Choi; Won-Seok Jung; Su-Young Jung; Jung-Hee Cho; Mee-Ok Choi; Ho-Joon Song; Sung-Joo Park
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

Review 9.  Alarmins, inflammasomes and immunity.

Authors:  Najwane Saïd-Sadier; David M Ojcius
Journal:  Biomed J       Date:  2012 Nov-Dec       Impact factor: 4.910

10.  Metformin protects against hyperglycemia-induced cardiomyocytes injury by inhibiting the expressions of receptor for advanced glycation end products and high mobility group box 1 protein.

Authors:  Ting Zhang; Xiaorong Hu; Yuli Cai; Bo Yi; Zhongyuan Wen
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.